These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22538694)

  • 1. The LINX® reflux management system: confirmed safety and efficacy now at 4 years.
    Lipham JC; DeMeester TR; Ganz RA; Bonavina L; Saino G; Dunn DH; Fockens P; Bemelman W
    Surg Endosc; 2012 Oct; 26(10):2944-9. PubMed ID: 22538694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center.
    Bonavina L; Saino G; Bona D; Sironi A; Lazzari V
    J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal comparison of quality of life in patients undergoing laparoscopic Toupet fundoplication versus magnetic sphincter augmentation: Observational cohort study with propensity score analysis.
    Asti E; Bonitta G; Lovece A; Lazzari V; Bonavina L
    Medicine (Baltimore); 2016 Jul; 95(30):e4366. PubMed ID: 27472725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement.
    Saino G; Bonavina L; Lipham JC; Dunn D; Ganz RA
    J Laparoendosc Adv Surg Tech A; 2015 Oct; 25(10):787-92. PubMed ID: 26437027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of the Magnetic Sphincter Augmentation Device: Surgical Technique and Results of a Single-center Cohort Study.
    Asti E; Siboni S; Lazzari V; Bonitta G; Sironi A; Bonavina L
    Ann Surg; 2017 May; 265(5):941-945. PubMed ID: 27163959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINX
    Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S
    Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.
    Ganz RA; Edmundowicz SA; Taiganides PA; Lipham JC; Smith CD; DeVault KR; Horgan S; Jacobsen G; Luketich JD; Smith CC; Schlack-Haerer SC; Kothari SN; Dunst CM; Watson TJ; Peters J; Oelschlager BK; Perry KA; Melvin S; Bemelman WA; Smout AJ; Dunn D
    Clin Gastroenterol Hepatol; 2016 May; 14(5):671-7. PubMed ID: 26044316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System.
    Fockens P; Bruno MJ; Gabbrielli A; Odegaard S; Hatlebakk J; Allescher HD; Rösch T; Rhodes M; Bastid C; Rey J; Boyer J; Muehldorffer S; van den Hombergh U; Costamagna G
    Endoscopy; 2004 Aug; 36(8):682-9. PubMed ID: 15280972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction.
    Noar MD; Noar E
    Surg Endosc; 2008 Nov; 22(11):2440-4. PubMed ID: 18437485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between gastroesophageal junction integrity and symptomatic fundoplication outcomes.
    Turner B; Helm M; Hetzel E; Schumm M; Gould JC
    Surg Endosc; 2020 Mar; 34(3):1387-1392. PubMed ID: 31214803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results.
    von Renteln D; Schiefke I; Fuchs KH; Raczynski S; Philipper M; Breithaupt W; Caca K; Neuhaus H
    Surg Endosc; 2009 Aug; 23(8):1866-75. PubMed ID: 19440792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation: One Year Results From a Post Approval Study.
    Louie BE; Smith CD; Smith CC; Bell RCW; Gillian GK; Mandel JS; Perry KA; Birkenhagen WK; Taiganides PA; Dunst CM; McCollister HM; Lipham JC; Khaitan LK; Tsuda ST; Jobe BA; Kothari SN; Gould JC
    Ann Surg; 2019 Aug; 270(2):302-308. PubMed ID: 29697454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark.
    Bjelović M; Harsányi L; Altorjay Á; Kincses Z; Forsell P;
    BMC Surg; 2020 Jul; 20(1):159. PubMed ID: 32689979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.